SBI Okasan Asset Management Co.Ltd. Makes New Investment in Danaher Corporation $DHR

SBI Okasan Asset Management Co.Ltd. bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 4th quarter, Holdings Channel.com reports. The firm bought 7,100 shares of the conglomerate’s stock, valued at approximately $1,637,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. JPL Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC acquired a new position in Danaher during the 4th quarter worth about $26,000. WFA of San Diego LLC acquired a new position in Danaher during the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd acquired a new position in Danaher during the 3rd quarter worth about $27,000. Finally, Financial Life Planners acquired a new position in Danaher during the 3rd quarter worth about $32,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have commented on DHR. Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Argus lowered their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. The Goldman Sachs Group lowered their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. TD Cowen lowered their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $238.24.

Danaher Stock Performance

NYSE:DHR opened at $180.47 on Friday. The company has a fifty day moving average of $182.29 and a 200-day moving average of $207.65. The firm has a market capitalization of $127.73 billion, a P/E ratio of 34.91, a P/E/G ratio of 2.31 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter in the previous year, the business posted $1.88 EPS. Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.